A Phase I Study to Evaluate XTR003 in Healthy Chinese Volunteers

Clinical trial NCT05136391 · COMPLETED

Trial details

NCT number: NCT05136391
Sponsor: Sinotau Pharmaceutical Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Coronary Artery Disease (CAD)

Start date: 2021-03-29
Primary completion: 2021-08-27
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.